Skip Navigation

VAERS Bibliography - September 2003

  1. One on One. Can I Get Whooping Cough Even If I Was Vaccinated As a Child? Mayo Clin Womens Healthsource.  4 (10): 8; October 2000.

  2. Update: Adverse Events Following Civilian Smallpox Vaccination--United States, 2003. MMWR Morb.Mortal.Wkly.Rep.  52 (34): 819-820; August 29, 2003.

  3. Vaccination Services in Postwar Iraq, May 2003. MMWR Morb.Mortal.Wkly.Rep.  52 (31): 734-735; August 8, 2003.

  4. National, State, and Urban Area Vaccination Levels Among Children Aged 19-35 Months--United States, 2002. MMWR Morb.Mortal.Wkly.Rep.  52 (31): 728-732; August 8, 2003.

  5. Pneumococcal Vaccination for Cochlear Implant Candidates and Recipients: Updated Recommendations of the Advisory Committee on Immunization Practices. MMWR Morb.Mortal.Wkly.Rep.  52 (31): 739-740; August 8, 2003.

  6. Vaccination Coverage Among Children Entering School--United States, 2002-03 School Year. MMWR Morb.Mortal.Wkly.Rep.  52 (33): 791-793; August 22, 2003.

  7. Vaccination Coverage Levels Among Alaska Native Children Aged 19-35 Months--National Immunization Survey, United States, 2000-2001. MMWR Morb.Mortal.Wkly.Rep.  52 (30): 710-713; August 1, 2003.

  8. Aaby, P.; Jensen, H.; Simondon, F.; Whittle, H.  High-Titer Measles Vaccination Before 9 Months of Age and Increased Female Mortality: Do We Have an Explanation? Semin Pediatr Infect Dis.  14 (3): 220-232; July 2003.

  9. Aragon, T. J.; Ulrich, S.; Fernyak, S. E.; Rutherford, G. W.  Risks of Serious Complications and Death From Smallpox Vaccination: A Systematic Review of the United States Experience, 1963-1968. BMC Public Health.  3 (1): 26; August 11, 2003.

  10. Atlas, R. M.; Clover, R.  Commentary on Implications of the 1971 Outbreak in Aralsk, Kazakhstan, for U.S. Smallpox Vaccination Policy (No. 1). Crit Rev Microbiol.  29 (2): 159-161; 2003.

  11. Ault, A.  US Advisory Panel Urges Government to Subsidise Vaccine Costs. Recommendations Would Increase Vaccination Rates and Stimulate Research and Development. Lancet.  362 (9383): 539; August 16, 2003.

  12. Bauch, C. T.; Galvani, A. P.; Earn, D. J.  Group Interest Versus Self-Interest in Smallpox Vaccination Policy. Proc Natl Acad Sci U S A. 100(18): 10564-10567, September 2, 2003.

  13. Bearman, G.; Fuentes, L.; Van Vorenkamp, J. L.; Drusin, L. M.  Vaccination Without Documentation: Influenza Immunization Among Medical Residents at a Tertiary-Care Medical Center. Infect Control Hosp.Epidemiol.  24 (8): 626-628; August 2003.

  14. Begue, P.  [Vaccination in France]. Arch Pediatr.  10 (6): 571-578; June, 2003.

  15. Bothamley, G. H.; Cooper, E.; Shingadia, D.; Mellanby, A.  Tuberculin Testing Before BCG Vaccination. BMJ.  327 (7409): 243-244; August 2, 2003.

  16. Butler, D.  WHO Prepares for Final Push to Rid the World of Polio. Nature.  424 (6949): 604; August 7, 2003.

  17. Charatan, F.  US Panel Advises Caution Over Smallpox Vaccination. BMJ.  327 (7412): 414; August 23, 2003.

  18. D'Amelio, R.; Biselli, R.; Natalicchio, S.; Lista, F.; Peragallo, M. S.  Vaccination Programmes in the Italian Military. Vaccine.  21 (25-26): 3530-3533; September 8, 2003.

  19. Deem, M. W.; Lee, H. Y.  Sequence Space Localization in the Immune System Response to Vaccination and Disease. Phys.Rev Lett.  91 (6): 068101; August 8, 2003.

  20. DeStefano, F.; Thompson, W. W.  MMR Vaccination and Autism: Is There a Link? Expert.Opin.Drug Saf.  1 (2): 115-120; July, 2002.

  21. Egede, L. E.  Association Between Number of Physician Visits and Influenza Vaccination Coverage Among Diabetic Adults With Access to Care. Diabetes Care.  26 (9): 2562-2567; September, 2003.

  22. Farrington, C. P.; Kanaan, M. N.; Gay, N. J.  Branching Process Models for Surveillance of Infectious Diseases Controlled by Mass Vaccination. Biostatistics.  4 (2): 279-295; April, 2003.

  23. Fedson, D. S.  Pneumococcal Vaccination in Older Adults. N.Engl.J Med.  349 (7): 712-714; August 14, 2003.

  24. Foxwell, A. R.; Cripps, A. W.; Dear, K. B.  Haemophilus Influenzae Oral Whole Cell Vaccination for Preventing Acute Exacerbations of Chronic Bronchitis. Cochrane Database Syst Rev.3): CD001958; 2003.

  25. Ghebrehewet, S.; Falconer, M.; McDonald, P.; Schlecht, B.  MMR Vaccine Uptake Rates: A Data Validation Study. Commun Dis Public Health.  6 (2): 144-146; June, 2003.

  26. Ghosh, T. K.  Controversies in Rabies Vaccination. Indian J Pediatr.  70 (6): 495-498; June, 2003.

  27. Hak, E.; Bonten, M. J.; Hoes, A. W.  Pneumococcal Vaccination in Older Adults. N.Engl.J Med.  349 (7): 712-714; August 14, 2003.

  28. Hammarlund, E.; Lewis, M. W.; Hansen, S. G.; Strelow, L. I.; Nelson, J. A.; Sexton, G. J.; Hanifin, J. M.; Slifka, M. K.  Duration of Antiviral Immunity After Smallpox Vaccination. Nat.Med.  9 (9): 1131-1137; September, 2003.

  29. Hanna, J. N.; Bullen, R. C.; Ziegler, C. L.; Akee, T.; Dostie, B. G.; Lort-Phillips, K.  An Assessment of the Implementation of the Pneumococcal Conjugate Vaccination Program for Aboriginal and Torres Strait Infants in North Queensland. Commun Dis Intell.  27 (2): 262-266; 2003.

  30. Hanslik, T.; Boelle, P. Y.; Schwarzinger, M.; Carrat, F.; Freedberg, K. A.; Valleron, A. J.; Flahault, A.  Varicella in French Adolescents and Adults: Individual Risk Assessment and Cost-Effectiveness of Routine Vaccination. Vaccine.  21 (25-26): 3614-3622; September 8, 2003.

  31. Hirschmann, J. V.  Pneumococcal Vaccination in Older Adults. N.Engl.J Med.  349 (7): 712-714; August 14, 2003.

  32. Hsu, H. C.; Lin, R. S.; Tung, T. H.; Chen, T. H.  Cost-Benefit Analysis of Routine Childhood Vaccination Against Chickenpox in Taiwan: Decision From Different Perspectives. Vaccine.  21 (25-26): 3982-3987; September 8, 2003.

  33. Isik, N.; Uzel, N.; Gokcay, G.; Kilic, A.; Yilmaz, G.; Sadikoglu, B.; Diri, S.  Seroconversion After Measles Vaccination at Nine and Fifteen Months of Age. Pediatr Infect Dis J.  22 (8): 691-695; August 2003.

  34. Jansen, V. A.; Stollenwerk, N.; Jensen, H. J.; Ramsay, M. E.; Edmunds, W. J.; Rhodes, C. J.  Measles Outbreaks in a Population With Declining Vaccine Uptake. Science.  301 (5634): 804; August 8, 2003.

  35. Jimenez, R.; Larrauri, A.; Carrasco, P.; Esteban, J.; Gomez-Lopez, L. I.; Gil, A.  Influenza Coverages in Spain and Vaccination-Related Factors in the Subgroup Aged 50-64 Years. Vaccine.  21 (25-26): 3550-3555; September 8, 2003.

  36. Jungbauer-Gans, M.; Kriwy, P.  [Influence Exercised by Physicians on the Vaccination Rate]. Gesundheitswesen.  65 (7): 464-470; July 2003.

  37. Kassianos, G.  Influenza Vaccination of Patients Receiving Cytotoxic Chemotherapy: Can We Do Better? Int J Clin Pract.  57 (6): 457-458; July 2003.

  38. Korobeinikov, A.; Maini, P. K.; Walker, W. J.  Estimation of Effective Vaccination Rate: Pertussis in New Zealand As a Case Study. J Theor.Biol.  224 (2): 269-275; September 21, 2003.

  39. Lane, J. M.; Goldstein, J.  Adverse Events Occurring After Smallpox Vaccination. Semin Pediatr Infect Dis.  14 (3): 189-195; July 2003.

  40. Leggat, P. A.  The Traveller's Pocket Medical Guide and International Certificate of Vaccination. J Travel.Med.  10 (4): 251; July 2003.

  41. Lloyd, J. C.; Haber, P.; Mootrey, G. T.; Braun, M. M.; Rhodes, P. H.; Chen, R. T.  Adverse Event Reporting Rates Following Tetanus-Diphtheria and Tetanus Toxoid Vaccinations: Data From the Vaccine Adverse Event Reporting System (VAERS), 1991-1997. Vaccine.  21 (25-26): 3746-3750; September 8, 2003.

  42. Lucas, A. H.; McLean, G. R.; Reason, D. C.; O'Connor, A. P.; Felton, M. C.; Moulton, K. D.  Molecular Ontogeny of the Human Antibody Repertoire to the Haemophilus Influenzae Type b Polysaccharide: Expression of Canonical Variable Regions and Their Variants in Vaccinated Infants.  Clin Immunol.  108 (2): 119-127; August 2003.

  43. Marras, T. K.  Pneumococcal Vaccination in Older Adults. N.Engl.J Med.  349 (7): 712-714; August 14, 2003.

  44. Minor, P. D.  Polio Vaccines and the Cessation of Vaccination. Expert.Rev Vaccines.  2 (1): 99-104; February, 2003.

  45. Moverare, R.  Immunological Mechanisms of Specific Immunotherapy With Pollen Vaccines: Implications for Diagnostics and the Development of Improved Vaccination Strategies. Expert.Rev Vaccines.  2 (1): 85-97; February, 2003.

  46. Nardelli-Haefliger, D.; Wirthner, D.; Schiller, J. T.; Lowy, D. R.; Hildesheim, A.; Ponci, F.; De Grandi, P.  Specific Antibody Levels at the Cervix During the Menstrual Cycle of Women Vaccinated With Human Papillomavirus 16 Virus-Like Particles. J Natl Cancer Inst.  95 (15): 1128-1137; August 6, 2003.

  47. Raufu, A.  Polio Vaccine Plans May Run into Problems in Nigeria. BMJ.  327 (7410): 380; August 9, 2003.

  48. Ring, A.; Marx, G.; Steer, C.; Prendiville, J.; Ellis, P.  Poor Uptake of Influenza Vaccinations in Patients Receiving Cytotoxic Chemotherapy. Int J Clin Pract.  57 (6): 542-543; July 2003.

  49. Samoilovich, E.; Roivainen, M.; Titov, L. P.; Hovi, T.  Serotype-Specific Mucosal Immune Response and Subsequent Poliovirus Replication in Vaccinated Children. J Med Virol.  71 (2): 274-280; October, 2003.

  50. Schroeder, B. M.  ACIP Issues Guidelines on the Use of Smallpox Vaccine in a Pre-Event Vaccination Program. Am Fam.Physician.  68 (3): 554, 557-554, 558; August 1, 2003.

  51. Skledar, S. J.; Hess, M. M.; Ervin, K. A.; Gross, P. R.; Nowalk, M. P.; Carter, H.; Zimmerman, R. K.; Middleton, D.  Designing a Hospital-Based Pneumococcal Vaccination Program. Am J Health Syst Pharm.  60 (14): 1471-1476; July 15, 2003.

  52. Thirlaway, K.; Lukman, H.  Meningitis C Vaccine Uptake by British Undergraduates. Commun Dis Public Health.  6 (2): 157-160; June, 2003.

  53. Tieman, J.  Vaccination Solutions. IOM Suggests Providers Be Reimbursed. Mod.Healthc.  33 (32): 12-13; August 11, 2003.

  54. Trzonkowski, P.; Mysliwska, J.; Szmit, E.; Wieckiewicz, J.; Lukaszuk, K.; Brydak, L. B.; Machala, M.; Mysliwski, A.  Association Between Cytomegalovirus Infection, Enhanced Proinflammatory Response and Low Level of Anti-Hemagglutinins During the Anti-Influenza Vaccination-an Impact of Immunosenescence. Vaccine.  21 (25-26): 3826-3836; September 8, 2003.

  55. Vedhara, K.; Bennett, P. D.; Clark, S.; Lightman, S. L.; Shaw, S.; Perks, P.; Hunt, M. A.; Philip, J. M.; Tallon, D.; Murphy, P. J.; Jones, R. W.; Wilcock, G. K.; Shanks, N. M.  Enhancement of Antibody Responses to Influenza Vaccination in the Elderly Following a Cognitive-Behavioural Stress Management Intervention. Psychother.Psychosom.  72 (5): 245-252; September, 2003.

  56. Verstraeten, T.; Jumaan, A. O.; Mullooly, J. P.; Seward, J. F.; Izurieta, H. S.; DeStefano, F.; Black, S. B.; Chen, R. T.  A Retrospective Cohort Study of the Association of Varicella Vaccine Failure With Asthma, Steroid Use, Age at Vaccination, and Measles-Mumps-Rubella Vaccination. Pediatrics.  112 (2): e98-103; August 2003.

  57. Vines, J.  [An Appraisal of the Pros and Cons of Mass Vaccination]. An Sist.Sanit.Navar.  20 (3): 391-394; September, 1997.

  58. von Herrath, M. G.  Vaccination to Prevent Type 1 Diabetes. Expert.Rev Vaccines.  1 (1): 25-28; June, 2002.

  59. Wongsurakiat, P.; Lertakyamanee, J.; Maranetra, K. N.; Jongriratanakul, S.; Sangkaew, S.  Economic Evaluation of Influenza Vaccination in Thai Chronic Obstructive Pulmonary Disease Patients. J Med Assoc Thai.  86 (6): 497-508; June, 2003.

[top]